Zoledronic acid - Malignancy
You are here : Home > Formulary Search > Zoledronic acid - Malignancy
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Zoledronic acid
Indication :
Malignancy
Group Name :
Keywords :
Hypercalcaemia of malignancy, Bone metastases, Prevention of skeletal events.
Brand Names Include :
Zometa
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Other Indications
Below are listed other indications that Zoledronic acid is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Malignancy.
Committee Recommendations (1)
24 Oct 07 -
Not Set
Zolendronic acid for malignancy is considered as a red drug - refer back to Acute Trust